The New Paradigm in Pharma R&D

Area of Science:

• Pharmacology and Pharmaceutical Sciences
• Biotechnology
• Biomedical Research

Background:

• The traditional vertically integrated large company model dominated drug discovery for over 50 years.
• Significant shifts in the drug discovery enterprise have occurred over the past 25 years.
• The pharmaceutical industry is undergoing a structural transformation.

Purpose of the Study:

• To analyze the evolving structure of the drug discovery enterprise.
• To highlight the transition from centralized to distributed models in pharmaceutical research.
• To identify key changes in the organization of drug development.

Main Methods:

• Analysis of industry trends in pharmaceutical research and development.
• Review of historical models of drug discovery.
• Examination of the organizational structures within the modern drug discovery ecosystem.

Main Results:

• The vertically integrated large company model is no longer the sole paradigm in drug discovery.
• A more distributed drug discovery enterprise has emerged, incorporating diverse organizational structures.
• Numerous small research organizations now play a significant role in the drug discovery process.

Conclusions:

• The drug discovery enterprise has become more decentralized.
• Collaboration and integration of small research organizations are increasingly important.
• The future of drug discovery involves a network of specialized entities rather than solely large corporations.